ocriplasmin

1
Reactions 1500, p29 - 10 May 2014 S Ocriplasmin Panretinal dysfunction: case report A 63-year-old woman developed panretinal dysfunction following intravitreous injection of ocriplasmin [outcome not stated]. The woman developed brilliant white photopsias several hours after intravitreous injection of ocriplasmin 0.125mg/0.1mL in the right eye for a small macular hole with vitreomacular adhesion. These photopsias progressed into multiple white floaters on a black background, with no perceptible vision in the injected eye. Although her vision improved over the next 4 days, she experienced nyctalopia and her vision developed a yellow tint. Nine days after injection, her corrected visual acuity was 20/125 in the right eye and 20/25 in the left eye. Fundus biomicroscopy showed a prepapillary vitreous ring in the right eye, with a full-thickness hole in the macula and diffuse attenuation of the retinal arterioles. Spectral-domain optical coherence tomography of the right eye demonstrated an enlarged full-thickness macular hole, with attenuation or loss of the external limiting membrane, photoreceptor ellipsoid layer and cone outer segment lips line. All isopters in the right eye were constricted. Electroretinography in the right eye showed that the rod B- wave was reduced to <10% of normal, the combined rod-cone response was reduced to ~50% of normal, and the 32-Hz flicker was reduced to ~40–50% of normal. Oscillatory potential amplitudes were severely reduced in the right eye. Author comment: The patient developed "acute severe panretinal dysfunction after ocriplasmin injection documented and quantified by fundus photography, Goldmann visual field testing, spectral-domain optical coherence tomography, and electrophysiological responses." Fahim AT, et al. Acute panretinal structural and functional abnormalities after intravitreous ocriplasmin injection. JAMA Ophthalmology 132: 484-486, No. 4, Apr 2014 - USA 803103064 1 Reactions 10 May 2014 No. 1500 0114-9954/14/1500-0001/$14.95 Adis © 2014 Springer International Publishing AG. All rights reserved

Upload: dothien

Post on 20-Jan-2017

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Ocriplasmin

Reactions 1500, p29 - 10 May 2014

SOcriplasmin

Panretinal dysfunction: case reportA 63-year-old woman developed panretinal dysfunction

following intravitreous injection of ocriplasmin [outcome notstated].

The woman developed brilliant white photopsias severalhours after intravitreous injection of ocriplasmin0.125mg/0.1mL in the right eye for a small macular hole withvitreomacular adhesion. These photopsias progressed intomultiple white floaters on a black background, with noperceptible vision in the injected eye. Although her visionimproved over the next 4 days, she experienced nyctalopia andher vision developed a yellow tint. Nine days after injection,her corrected visual acuity was 20/125 in the right eye and20/25 in the left eye. Fundus biomicroscopy showed aprepapillary vitreous ring in the right eye, with a full-thicknesshole in the macula and diffuse attenuation of the retinalarterioles. Spectral-domain optical coherence tomography ofthe right eye demonstrated an enlarged full-thickness macularhole, with attenuation or loss of the external limitingmembrane, photoreceptor ellipsoid layer and cone outersegment lips line. All isopters in the right eye were constricted.Electroretinography in the right eye showed that the rod B-wave was reduced to <10% of normal, the combined rod-coneresponse was reduced to ~50% of normal, and the 32-Hzflicker was reduced to ~40–50% of normal. Oscillatorypotential amplitudes were severely reduced in the right eye.

Author comment: The patient developed "acute severepanretinal dysfunction after ocriplasmin injectiondocumented and quantified by fundus photography,Goldmann visual field testing, spectral-domain opticalcoherence tomography, and electrophysiological responses."Fahim AT, et al. Acute panretinal structural and functional abnormalities afterintravitreous ocriplasmin injection. JAMA Ophthalmology 132: 484-486, No. 4,Apr 2014 - USA 803103064

1

Reactions 10 May 2014 No. 15000114-9954/14/1500-0001/$14.95 Adis © 2014 Springer International Publishing AG. All rights reserved